P revious analysis of hospitalization trends among HIV-infected children and adolescents in the United States (US) from 1994 to 2003 indicated that there were dramatic decreases in the number of hospitalizations with the widespread use of highly active antiretroviral therapy (HAART) in the US. 1 Since 2003, the pediatric HIV treatment guidelines have evolved, with greater emphasis on starting combination antiretroviral therapy very early in life. 2, 3 Guidelines for the prevention and treatment of opportunistic infections among HIV-infected children have also changed during this time period. 4, 5 Other potential factors that may have more recently influenced the number of hospitalizations include increased use of preventive strategies, such as the pneumococcal conjugate vaccine (PCV) 6 and the influenza vaccine. 7 The purpose of this study was to update and expand on the previous analysis using more recent data to describe trends in hospitalizations for children and adolescents ≤18 years of age with HIV infection in the US during [2003] [2004] [2005] [2006] [2007] [2008] [2009] [2010] [2011] [2012] . Information on recent trends in hospitalizations of HIV-infected children is important in a climate of rapidly changing health care and practices to identify potential areas for future research.
METHODS

Description of the Database
The Kids´ Inpatient Database (KID) is part of the Healthcare Cost and Utilization Project of the Agency for Healthcare Research and Quality and is the largest publicly-available all-payer pediatric inpatient care database in the US. 8 It is released every 3 years; we used 2003, 2006, 2009 and 2012 data for this analysis. The KID is a sample of pediatric discharges (defined as discharges where a patient was ≤20 years at admission) from all community, nonrehabilitation hospitals in participating states. 8, 9 Pediatric discharges are stratified by reason for hospital stay (uncomplicated in-hospital birth, complicated in-hospital birth and all other pediatric cases). The KID is constructed using systematic random sampling to select a percentage of discharges by reason for hospital stay. 8 The KID contains information on about 3 million hospital stays from an average of about 3800 hospitals for each year studied. The discharge records in the KID do not contain a patient identifier, and thus repeat hospitalizations cannot be identified. To obtain national estimates, hospitals are poststratified by 6 characteristics (geographic region, ownership, rural/urban location, teaching status, bed size and hospital type), and discharge weights for each record are created to account for the complex sampling design. 8 Hospital discharge diagnoses and procedures were coded according to the International Classification of Diseases, 9th revision, Clinical Modification (ICD-9-CM) and the Clinical Classifications Software (CCS) tool, developed by the Agency for Healthcare Research and Quality for clustering diagnoses and procedures into clinically meaningful categories.
adolescents. For comparison, these same trends were examined in hospitalizations of HIV-uninfected children. The term "children" is used throughout the article and refers to both children and adolescents. Data from children who were ≤18 years were included in these analyses for consistency with the age range used in the prior analysis. 1 Hospitalizations for conditions related to pregnancy and delivery (ICD-9-CM codes are in Appendix, Supplemental Digital Content 1, http://links.lww.com/INF/C736) and hospitalizations for neonatal diagnoses (using the neomat variable in the KID that flags hospitalizations for neonates) were excluded.
Our outcomes of interest included deaths during hospitalization, hospital charges and select discharge diagnoses and procedures. Hospital charges were adjusted to 2012 dollars using 
RESULTS
We estimated that there were 1343 hospitalizations among children with an HIV diagnosis in the US in 2012 compared with 3172 in 2003, which is a 58% decrease (Table 1) Additionally, the odds of having discharge codes for most diagnoses and procedures of interest were higher among hospitalizations of HIV-infected compared with HIV-uninfected children in both 2003 and 2012 (Table 2) . Adjusting for age and sex generally had little effect on the estimated associations presented in Table 2 , with a small number of exceptions. For example, the unadjusted odds ratio (OR) for HIV and bacterial infections/sepsis was 1.02 (95% CI: 0.91-1.15), while the aOR was 1.41 (1.22-1.62). This Figure 1 and for varicella/herpes zoster and MRSA in Figure 2 . Among hospitalized HIV-infected children, the odds of discharge diagnoses for pneumonia, pneumococcal disease and varicella/herpes zoster infections decreased significantly from 2003 Table 3 ).
Similar trends were observed among hospitalizations of HIV-uninfected children for deaths during hospitalization and discharge diagnoses for pneumonia, pneumococcal disease, varicella/ herpes zoster infections and MRSA (Table 3 and Figs. 1 and 2) . Conversely, the decreases observed for hospitalizations with the discharge diagnosis of pneumonia were greater for HIV-infected, compared with uninfected children (test for interaction: P = 0.02). There were also significant interactions between year and infection status for discharge diagnoses for bacterial infections/sepsis and influenza. Among HIV-uninfected children, the odds of discharge diagnoses for bacterial infections/sepsis remained fairly stable (P = 0.02) and influenza generally decreased over time with an increase in 2009 that was more modest than for HIV-infected children (P = 0.01). In addition, there were increases in discharge diagnoses for mycoses, Mycobacterium avium infections and cytomegalovirus among HIV-uninfected children (Table 3) .
Regarding procedures of interest, use of antibiotic injections decreased significantly for both HIV-infected and uninfected hospitalized children (Table 3 ). The odds of other procedures studied did not change significantly for HIV-infected children.
DISCUSSION
In this analysis of multiple years of nationally representative data on hospital admissions in the US, we found that the estimated numbers of hospitalizations among HIV-infected children and adolescents ≤18 years decreased by 58% from 2003 to 2012. US wide HIV surveillance data show a decrease in the number of youth ≤19 years living with a diagnosed HIV infection in the US (from an estimated 11,997 in 2009 to 9790 in 2012). 12, 13 The decrease in the estimated numbers of hospitalizations among HIV-infected children and adolescents ≤18 years mirrors the 71% decrease from 1994 to 2003 noted in our previous analysis. 1 That decrease was noted to have occurred since the advent of HAART in the US around 1997. Since 2003, antiretroviral therapy regimens have improved and treatment has become more aggressive, which may contribute to this continued decline. 3, 14, 15 Another factor that may be contributing to the decreasing numbers of hospitalizations could be the shift in age patterns as HIV-infected adolescents age out of this population. From 2009 to 2014, the overall estimated rates of new HIV diagnoses for adolescents 15-19 years have been decreasing (from 10.3 to 8.7 per 100,000 population). 12, 13 The rates for adolescents 13-14 years and children younger than 13 have been more stable from 2009 to 2014 and are fairly low (0.4 and 0.3, respectively, per 100,000 population in 2014). 12, 13 We found that the rates and odds of death during hospitalization for HIV-infected children decreased from 2003 to 2012 but were still higher than the odds for HIV-uninfected children. Two prior studies have shown that mortality rates for HIV-infected children are about 30 times higher than rates for the general US pediatric population. 16, 17 Another study found declining hospitalization rates from 2003 to 2010 among 5-16 and 17-24 year olds perinatally infected with HIV. 18 While use of HAART has led to decreases in mortality for HIV-infected children, 19 finding the optimal treatment strategies remains a challenge, particularly for adolescents who are likely to face adherence issues. 20, 21 The rates and aORs of most of the outcomes described in this analysis were higher among hospitalizations of HIV-infected children compared with HIV-uninfected children in all years studied (2003, 2006, 2009 and 2012) . The trends examined show decreases in the likelihood of discharge codes for pneumonia, pneumococcal disease and varicella/herpes zoster infections among hospitalized HIV-infected children but increases in discharge codes for bacterial infections/sepsis and MRSA.
The increase in discharge codes for bacterial infections/sepsis is in contrast to the decrease noted in our previously published analysis comparing the pre-HAART (1994) (1995) (1996) and HAART (2001 HAART ( -2003 eras. 1 In a recent systematic review and meta-analysis of the causes of hospital admissions among people living with HIV worldwide, AIDS-related illnesses and bacterial infections were the leading causes of hospitalization among children. 22 It should be noted that the incidence of hospitalizations with coding for sepsis has increased in the US, while hospitalizations with objective clinical markers of infection have remained stable or decreased, 23 likely reflecting changes in coding practices. Although this could explain the increases we found in discharge diagnoses for infections in HIV-infected pediatric population, particularly those >10 years of age, a corresponding increase was not observed among HIV-uninfected children.
We found that the prevalence of hospitalizations with discharge diagnoses for pneumococcal disease decreased from 2003 to 2012, coinciding with the introduction of the 7-valent PCV in the US in 2000 and 13-valent PCV in 2010. 24 An analysis of hospitalization trends for invasive pneumococcal disease among HIV-infected adolescents and adults noted a significant decrease in 2004-2005 compared with 1994-1995. 25 The Centers for Disease Control estimates that 92.3% of children 19-35 months of age received ≥3 doses of PCV in 2012. 6 Invasive MRSA infection incidence in children has been reported to have increased during the early part of our study period, 26 but there is evidence that it may be now decreasing, 27, 28 consistent with our findings that the rate per 1000 hospitalizations decreased from 2009 to 2012 for both HIV-infected and uninfected children.
The increase in incidence of discharge diagnoses of influenza in 2009 is because of the H1N1 pandemic. 29 The decreases noted for HIV-uninfected children for 2006 and 2012 compared with 2003 may be because of increased uptake of the seasonal influenza vaccine. 7 Similar decreases were not noted for hospitalizations among HIV-infected children, possibly because of influenza vaccinations not being as effective in HIV-infected young children. 30 There was a downward trend in hospitalizations among children with discharge diagnoses of varicella/herpes zoster infections, in contrast to cytomegalovirus, another opportunistic viral pathogen for which there is no vaccine available, which has not changed. The Centers for Disease Control estimates that 90.2 % of children age 19-35 months had received ≥1 dose of varicella vaccine in 2012. 6 The vaccine is recommended for all but the most severely immunocompromised HIV-infected children. 31 This study has some limitations. The sampling frame for the KID changes over time as states are added (e.g. 36 in 2003 and 44 in 2012), so estimates from earlier years may be subject to more sampling bias than later years. 8 A few states prohibit the release of discharge records for patients with an HIV diagnosis. The KID includes discharge records for patients up to 20 years of age at admission, but some states suppress the reporting of age for children with an HIV diagnosis. Although our analysis was limited to children ≤18 years, we included records where age was suppressed. Assuming the age distribution for these children was similar to those with a reported age, ~33 records in 2003 and ~67 in 2012 included may be for HIV-infected children >18 years old at admission. We analyzed data for all discharge diagnoses, so some conditions may not have been the reason for hospital admission. However, this provided a full picture of the morbidity burden of hospitalized HIV-infected children.
Other limitations include those common to research using administrative data: The data reflect hospital discharges rather than individual patients, so some children may be represented more than once for any given year, as well as across years. The resulting interdependence of observations could increase the likelihood that the associations measured were found significant and is important to take into account when interpreting the results. Because of incomplete data on race, we were unable to evaluate its effect on our estimates. Codes used for some conditions may have poor sensitivity or positive predictive value. 32, 33 Changes in health care and in coding practices over time may have influenced some of the trends observed. Strengths of this analysis include the large, nationally representative sample and the availability of charge and length of stay data.
CONCLUSION
Our results demonstrate that despite decreasing numbers of hospitalizations among HIV-infected children, the rates and adjusted odds of most of the outcomes examined are still higher among hospitalized HIV-infected children compared with HIVuninfected children from 2003 to 2012. The trends in discharge diagnoses among hospitalized HIV-infected children are generally similar to the trends for HIV-uninfected children with decreases in the prevalence of discharge codes for pneumonia, pneumococcal disease and varicella/herpes zoster infections and an increase in MRSA. The most notable exception is the trend of increasing prevalence of discharge diagnoses for bacterial infection/sepsis among hospitalized HIV-infected children which is not seen among HIV-uninfected children. Further research is warranted to address evolving trends and causes of this important issue for this population as it may impact treatment guidelines.
